Lori Lyons-Williams's Net Worth

$601 Thousand

Estimate Recalculated Sep 8, 2024 07:22PM EST

Who is Lori Lyons-Williams?

Lori Lyons-Williams does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RAPT Therapeutics, Inc., Dermira, Inc., FIVE PRIME THERAPEUTICS, INC., and Contineum Therapeutics, Inc..

SEC CIK

Lori Lyons-Williams's CIK is 0001693564

Past Insider Trading and Trends

2019 was Lori Lyons-Williams's most active year for acquiring shares with 5 total transactions. Lori Lyons-Williams's most active month to acquire stocks was the month of April. 2020 was Lori Lyons-Williams's most active year for disposing of shares, totalling 7 transactions. Lori Lyons-Williams's most active month to dispose stocks was the month of January. 2018 saw Lori Lyons-Williams paying a total of $1,800,937.50 for 135,443 shares, this is the most they've acquired in one year. In 2020 Lori Lyons-Williams cashed out on 305,529 shares for a total of $476,268.75, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

RAPT Therapeutics, Inc. (RAPT) Snapshot price: $1.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Nov 9
Form 3
—
0
—
—
0
No matching records found

Dermira, Inc. No price found

Chief Commercial Officer

Lori Lyons-Williams used to own units in Common Stock but no longer holds any shares there. In the year 2017 Lori Lyons-Williams filed a total of 8 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-25.40K
$18.75
-$476,268.75
0
Feb 20
Form 4
+6.75%
1.61K
$7.91
-$12,513.62
25.4K
Aug 15
Form 4
+470.87%
19.63K
$10.50
-$108,927.00
23.79K
May 17
Form 4
—
0
—
—
0
Feb 12
Form 4
+36.18%
695
$9.58
-$3,525.44
2.62K
Aug 15
Form 4
—
0
—
—
0
Feb 15
Form 4
—
0
—
—
0
Jan 9
Form 3
—
0
—
—
0
No matching records found

FIVE PRIME THERAPEUTICS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 16
Form 4
—
0
—
—
0
May 14
Form 4
—
0
—
—
0
Jun 23
Form 3
—
0
—
—
0
No matching records found

Contineum Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 24
Form 3
—
0
—
—
0
No matching records found